Navigation Links
Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
Date:5/17/2012

there at the Surgery Branch.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation in immunotherapy. One of its platform technologies relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Cautionary Note Regarding Forward-Looking Statements

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to h
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Generex Provides Clarification for Special Meeting Voting
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014  CVS Caremark Corporation (NYSE: CVS ... August 5, 2014, at 8:30 a.m. (EDT) with analysts ... results. An audio webcast of the conference ... portion of the CVS Caremark website for all interested ... This webcast will be archived and available on the ...
(Date:7/25/2014)...  Acsis Inc., the market leader for supply ... recently posted an article, "Future of Running ... needs for companies, extended supply chain, and explains ... no longer work today.  The article explains how ... mobile technology, machine to machine (M2M) connectivity, and ...
(Date:7/25/2014)... 2014 Research and Markets has ... Devices Market 2014-2018" report to their offering. ... Ophthalmic Diagnostic Device An ophthalmic diagnostic ... defect or deficiency in the human visual pathway. Ophthalmic ... as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, and dry ...
Breaking Medicine Technology:Acsis Addresses Questions on the Modern Supply Chain 2Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
... 16 Medicare has been touting the merits of the "competitive" bidding program for durable, or home medical equipment ... facts that exaggerate the benefits and ignore the severe shortcomings of the program. , ... ... , ...
... Pharmaceuticals Inc. (Nasdaq: OSIP ) that it will nominate a full and competing slate of independent directors at OSI Pharmaceuticals, 2010 annual stockholders, meeting. , ... , ... ... ...
Cached Medicine Technology:Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 2Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 3Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 4Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 5Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 2Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 3Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 4Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 5Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 6Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 7Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 8Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 9Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 10
(Date:7/28/2014)... 2014 Maternal and Family Health Services ... which will be presented at the agency’s 43rd Annual ... at the Westmoreland Club in Wilkes-Barre. , The late ... long-time employee of MFHS. She dedicated her life ... health advocate, and champion for women, children and families ...
(Date:7/28/2014)... study has found that following a healthy lifestyle may ... syndrome. Published early online in CANCER , a ... indicate that children with cancer and adults who had ... how their lifestyle may influence their long-term health. ... to be at increased risk for the metabolic syndrome, ...
(Date:7/28/2014)... 28, 2014 As health insurers design ... to private exchanges. “Private Exchange Strategies for Insurers: ... from Atlantic Information Services, will provide answers to the ... for the future. , Barbara Gniewek, Jonathan Har-Even and ... experience in the private exchange sector — will provide ...
(Date:7/28/2014)... 28, 2014 Mitul R. Patel, DDS ... at the MGE Management Experts Benefit Dinner May 30, ... joined the Dentists to raise funds for the Improving ... Girls Clubs and Youth Programs across America. The funds ... with books and audio books to directly tackle illiteracy ...
(Date:7/28/2014)... Cuidado Casero , an organization of Medicare certified agencies ... Texas, New Mexico, New Jersey, Virginia, and Puerto Rico, was ... of PAM’s 2014 Gala. , North Texas PAMS is ... Texas chapter was created by a handful of Peruvian physicians ... care for the indigent in Peru. The chapter is developing ...
Breaking Medicine News(10 mins):Health News:MFHS Seeking Nominations for Rose Allan Tucker Award 2Health News:Lifestyle choices may affect the long-term heart health of childhood cancer survivors 2Health News:Three PwC Consultants to Offer Insurers Successful Strategies for Private Exchanges 2Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 2Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 3Health News:Cuidado Casero Sponsors Peruvian American Medical Society (PAMS) Gala 2
... traditional medicinal system, the Indian Council of Medical Research (ICMR) ... develop drugs //from medicinal plants or multi-herb formulations that have ... valid for next five years was signed by ICMR Director ... K Gupta., ,As per the MoU, the ICMR will ...
... shortfall of the tissue culture variety of anti-rabies vaccine, ... of the restricted nerve tissue variety vaccine till the ... minister Surjyakanta Mishra told reporters here today that the ... few years ago citing side-effects., ,"However, since the ...
... shown by an increased nighttime BP than with a traditional ... researchers at Uppsala University revealed that a high blood pressure ... heart failure. ,Congestive heart failure (CHF) is ... Once diagnosed as having CHF, patients have a 1 in ...
... demand for traditional Indian medicine, a four-year degree course ... University (JU) for the first time in eastern India//. ... second of its kind in the country after Gujarat, ... Sciences (BIPS) in joint venture with West Bengal Health ...
... women has shown that those who indulged in six or ... 3 percent reduction in risk of type 2 diabetes, vis ... scientists were not able to place their finger on the ... they strongly feel that the presence of antioxidants and minerals ...
... MMR vaccine has been shrouded in controversy. Now, Britain's reputed ... to the raging //debates over this vaccine. ,Infact they have ... threat to young lives by forsaking the triple shots of ... and the media to defuse the entire furore over the ...
Cached Medicine News:Health News:Increased Nighttime BP, a Significant Predictor of Congestive Heart Failure 2
All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Intended for one-time use....
Used to provide bladder drainage by percutaneous placement of a balloon catheter. Supplied sterile in peel-open packages. Intended for one-time use....
Used to establish and temporarily maintain suprapubic access during endoscopic procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Used for pulling sutures from a vaginal incision into the suprapubic area during bladder suspension surgery. The double needle design permits simultaneous suture placement. Supplied sterile in peel-o...
Medicine Products: